-
Je něco špatně v tomto záznamu ?
Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system
M. Palus, J. Vojtíšková, J. Salát, J. Kopecký, L. Grubhoffer, M. Lipoldová, P. Demant, D. Růžek,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
BioMedCentral
od 2004-01-12
BioMedCentral Open Access
od 2004
Directory of Open Access Journals
od 2004
Free Medical Journals
od 2004
PubMed Central
od 2004
Europe PubMed Central
od 2004
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2004-01-01
Open Access Digital Library
od 2004-04-01
Open Access Digital Library
od 2004-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2004
Springer Nature OA/Free Journals
od 2004-12-01
PubMed
23805778
DOI
10.1186/1742-2094-10-77
Knihovny.cz E-zdroje
- MeSH
- buněčná imunita imunologie MeSH
- centrální nervový systém patologie MeSH
- chemokiny biosyntéza MeSH
- cytokiny biosyntéza MeSH
- genotyp MeSH
- klíšťová encefalitida imunologie patologie MeSH
- kvantitativní polymerázová řetězová reakce MeSH
- membránové proteiny biosyntéza MeSH
- messenger RNA biosyntéza genetika MeSH
- mozek - chemie fyziologie MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- náchylnost k nemoci MeSH
- neutralizující protilátky biosyntéza MeSH
- odolnost vůči nemocem MeSH
- plakové testy MeSH
- protilátky virové biosyntéza genetika MeSH
- virová nálož MeSH
- viry klíšťové encefalitidy * MeSH
- zánět patologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: The clinical course of tick-borne encephalitis (TBE), a disease caused by TBE virus, ranges from asymptomatic or mild influenza-like infection to severe debilitating encephalitis or encephalomyelitis. Despite the medical importance of this disease, some crucial steps in the development of encephalitis remain poorly understood. In particular, the basis of the disease severity is largely unknown. METHODS: TBE virus growth, neutralizing antibody response, key cytokine and chemokine mRNA production and changes in mRNA levels of cell surface markers of immunocompetent cells in brain were measured in mice with different susceptibilities to TBE virus infection. RESULTS: An animal model of TBE based on BALB/c-c-STS/A (CcS/Dem) recombinant congenic mouse strains showing different severities of the infection in relation to the host genetic background was developed. After subcutaneous inoculation of TBE virus, BALB/c mice showed medium susceptibility to the infection, STS mice were resistant, and CcS-11 mice were highly susceptible. The resistant STS mice showed lower and delayed viremia, lower virus production in the brain and low cytokine/chemokine mRNA production, but had a strong neutralizing antibody response. The most sensitive strain (CcS-11) failed in production of neutralizing antibodies, but exhibited strong cytokine/chemokine mRNA production in the brain. After intracerebral inoculation, all mouse strains were sensitive to the infection and had similar virus production in the brain, but STS mice survived significantly longer than CcS-11 mice. These two strains also differed in the expression of key cytokines/chemokines, particularly interferon gamma-induced protein 10 (IP-10/CXCL10) and monocyte chemotactic protein-1 (MCP-1/CCL2) in the brain. CONCLUSIONS: Our data indicate that the genetic control is an important factor influencing the clinical course of TBE. High neutralizing antibody response might be crucial for preventing host fatality, but high expression of various cytokines/chemokines during TBE can mediate immunopathology and be associated with more severe course of the infection and increased fatality.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14040683
- 003
- CZ-PrNML
- 005
- 20230808121839.0
- 007
- ta
- 008
- 140107s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/1742-2094-10-77 $2 doi
- 035 __
- $a (PubMed)23805778
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Palus, Martin
- 245 10
- $a Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system / $c M. Palus, J. Vojtíšková, J. Salát, J. Kopecký, L. Grubhoffer, M. Lipoldová, P. Demant, D. Růžek,
- 520 9_
- $a BACKGROUND: The clinical course of tick-borne encephalitis (TBE), a disease caused by TBE virus, ranges from asymptomatic or mild influenza-like infection to severe debilitating encephalitis or encephalomyelitis. Despite the medical importance of this disease, some crucial steps in the development of encephalitis remain poorly understood. In particular, the basis of the disease severity is largely unknown. METHODS: TBE virus growth, neutralizing antibody response, key cytokine and chemokine mRNA production and changes in mRNA levels of cell surface markers of immunocompetent cells in brain were measured in mice with different susceptibilities to TBE virus infection. RESULTS: An animal model of TBE based on BALB/c-c-STS/A (CcS/Dem) recombinant congenic mouse strains showing different severities of the infection in relation to the host genetic background was developed. After subcutaneous inoculation of TBE virus, BALB/c mice showed medium susceptibility to the infection, STS mice were resistant, and CcS-11 mice were highly susceptible. The resistant STS mice showed lower and delayed viremia, lower virus production in the brain and low cytokine/chemokine mRNA production, but had a strong neutralizing antibody response. The most sensitive strain (CcS-11) failed in production of neutralizing antibodies, but exhibited strong cytokine/chemokine mRNA production in the brain. After intracerebral inoculation, all mouse strains were sensitive to the infection and had similar virus production in the brain, but STS mice survived significantly longer than CcS-11 mice. These two strains also differed in the expression of key cytokines/chemokines, particularly interferon gamma-induced protein 10 (IP-10/CXCL10) and monocyte chemotactic protein-1 (MCP-1/CCL2) in the brain. CONCLUSIONS: Our data indicate that the genetic control is an important factor influencing the clinical course of TBE. High neutralizing antibody response might be crucial for preventing host fatality, but high expression of various cytokines/chemokines during TBE can mediate immunopathology and be associated with more severe course of the infection and increased fatality.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a neutralizující protilátky $x biosyntéza $7 D057134
- 650 _2
- $a protilátky virové $x biosyntéza $x genetika $7 D000914
- 650 _2
- $a mozek - chemie $x fyziologie $7 D001923
- 650 _2
- $a centrální nervový systém $x patologie $7 D002490
- 650 _2
- $a chemokiny $x biosyntéza $7 D018925
- 650 _2
- $a cytokiny $x biosyntéza $7 D016207
- 650 _2
- $a odolnost vůči nemocem $7 D060467
- 650 _2
- $a náchylnost k nemoci $7 D004198
- 650 12
- $a viry klíšťové encefalitidy $7 D004669
- 650 _2
- $a klíšťová encefalitida $x imunologie $x patologie $7 D004675
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a buněčná imunita $x imunologie $7 D007111
- 650 _2
- $a zánět $x patologie $7 D007249
- 650 _2
- $a membránové proteiny $x biosyntéza $7 D008565
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a messenger RNA $x biosyntéza $x genetika $7 D012333
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 650 _2
- $a virová nálož $7 D019562
- 650 _2
- $a plakové testy $7 D010948
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vojtíšková, Jarmila $u -
- 700 1_
- $a Salát, Jiří $u -
- 700 1_
- $a Kopecký, Jan $u -
- 700 1_
- $a Grubhoffer, Libor $u -
- 700 1_
- $a Lipoldová, Marie $u -
- 700 1_
- $a Demant, Peter $u -
- 700 1_
- $a Růžek, Daniel, $d 1981- $7 stk2008441707
- 773 0_
- $w MED00163330 $t Journal of neuroinflammation $x 1742-2094 $g Roč. 10, č. - (2013), s. 77
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23805778 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140107 $b ABA008
- 991 __
- $a 20230808121836 $b ABA008
- 999 __
- $a ok $b bmc $g 1005079 $s 839195
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 10 $c - $d 77 $i 1742-2094 $m Journal of neuroinflammation $n J Neuroinflammation $x MED00163330
- LZP __
- $a Pubmed-20140107